BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32591522)

  • 1. Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery.
    Voskuil FJ; Steinkamp PJ; Zhao T; van der Vegt B; Koller M; Doff JJ; Jayalakshmi Y; Hartung JP; Gao J; Sumer BD; Witjes MJH; van Dam GM;
    Nat Commun; 2020 Jun; 11(1):3257. PubMed ID: 32591522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent.
    Steinkamp PJ; Voskuil FJ; van der Vegt B; Doff JJ; Schepman KP; de Visscher SAHJ; Kelder W; Jayalakshmi Y; Gao J; Sumer BD; van Dam GM; Witjes MJH
    Mol Imaging Biol; 2021 Dec; 23(6):809-817. PubMed ID: 34031845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Activatable Clinical Nanoprobe for Cancer Imaging.
    Reichel D; Tripathi M; Butte P; Saouaf R; Perez JM
    Nanotheranostics; 2019; 3(2):196-211. PubMed ID: 31183314
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating tumor metastatic potential by imaging intratumoral acidosis via pH-activatable near-infrared fluorescent probe.
    Wang L; Fan Z; Zhang J; Changyi Y; Huang C; Gu Y; Xu Z; Tang Z; Lu W; Wei X; Li C
    Int J Cancer; 2015 Feb; 136(4):E107-16. PubMed ID: 25155456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise tumor delineation in clinical tissues using a novel acidic tumor microenvironment activatable near-infrared fluorescent contrast agent.
    Ling CC; Sun T; Chen F; Wu H; Tao W; Xie X; Ji D; Gao G; Chen J; Ling Y; Zhang Y
    Anal Chim Acta; 2023 Oct; 1279():341815. PubMed ID: 37827620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypeptide micelles with dual pH activatable dyes for sensing cells and cancer imaging.
    Gong P; Yang Y; Yi H; Fang S; Zhang P; Sheng Z; Gao G; Gao D; Cai L
    Nanoscale; 2014 May; 6(10):5416-24. PubMed ID: 24714804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-Activatable tumor-targeting gold nanoprobe for near-infrared fluorescence/CT dual-modal imaging in vivo.
    Tang Y; Shi H; Cheng D; Zhang J; Lin Y; Xu Y; Qian X; Zhu W
    Colloids Surf B Biointerfaces; 2019 Jul; 179():56-65. PubMed ID: 30947084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transistor-like Ultra-pH-Sensitive Polymeric Nanoparticles.
    Feng Q; Wilhelm J; Gao J
    Acc Chem Res; 2019 Jun; 52(6):1485-1495. PubMed ID: 31067025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pH-Activatable Nanoprobe Labels Diverse Histologic Subtypes of Human Lung Cancer During Resection.
    Kennedy GT; Azari FS; Chang A; Chang A; Bou-Samra P; Desphande C; Delikatny EJ; Eruslanov E; Kucharczuk JC; Rice DC; Singhal S
    Mol Imaging Biol; 2023 Oct; 25(5):824-832. PubMed ID: 37697109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical molecular imaging for tumor detection and image-guided surgery.
    Wang C; Wang Z; Zhao T; Li Y; Huang G; Sumer BD; Gao J
    Biomaterials; 2018 Mar; 157():62-75. PubMed ID: 29245052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratiometric fluorescence nanoparticle based on SiRB for pH detection of tumor.
    Wang Q; Ding X; Wang Y; Du Q; Xu T; Du B; Yao H
    Eur J Pharm Sci; 2018 Jun; 118():32-39. PubMed ID: 29551530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-pH-sensitive indocyanine green-conjugated nanoprobes for fluorescence imaging-guided photothermal cancer therapy.
    Li Z; Yin Q; Chen B; Wang Z; Yan Y; Qi T; Chen W; Zhang Q; Wang Y
    Nanomedicine; 2019 Apr; 17():287-296. PubMed ID: 30763723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simple, pH-Activatable Fluorescent Aptamer Probe with Ultralow Background for Bispecific Tumor Imaging.
    Shi H; Lei Y; Ge J; He X; Cui W; Ye X; Liu J; Wang K
    Anal Chem; 2019 Jul; 91(14):9154-9160. PubMed ID: 31185714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
    Gao RW; Teraphongphom NT; van den Berg NS; Martin BA; Oberhelman NJ; Divi V; Kaplan MJ; Hong SS; Lu G; Ertsey R; Tummers WSFJ; Gomez AJ; Holsinger FC; Kong CS; Colevas AD; Warram JM; Rosenthal EL
    Cancer Res; 2018 Sep; 78(17):5144-5154. PubMed ID: 29967260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Driven Targeting Nanoprobe with Dual-Responsive Drug Release for Persistent Luminescence Imaging and Chemotherapy of Tumor.
    Zhang HJ; Zhao X; Chen LJ; Yang CX; Yan XP
    Anal Chem; 2020 Jan; 92(1):1179-1188. PubMed ID: 31818096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the Utility and Limitations of Repurposing an Open-Field Optical Imaging Device for Fluorescence-Guided Surgery in Head and Neck Cancer Patients.
    Moore LS; Rosenthal EL; Chung TK; de Boer E; Patel N; Prince AC; Korb ML; Walsh EM; Young ES; Stevens TM; Withrow KP; Morlandt AB; Richman JS; Carroll WR; Zinn KR; Warram JM
    J Nucl Med; 2017 Feb; 58(2):246-251. PubMed ID: 27587708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled peptide nanoparticles as tumor microenvironment activatable probes for tumor targeting and imaging.
    Zhao Y; Ji T; Wang H; Li S; Zhao Y; Nie G
    J Control Release; 2014 Mar; 177():11-9. PubMed ID: 24417969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer.
    Murahari MS; Yergeri MC
    Curr Pharm Des; 2013; 19(25):4622-40. PubMed ID: 23363442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC.
    Pan J; Deng H; Hu S; Xia C; Chen Y; Wang J; Wang Y
    World J Surg Oncol; 2020 May; 18(1):96. PubMed ID: 32414418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.
    Li X; Schumann C; Albarqi HA; Lee CJ; Alani AWG; Bracha S; Milovancev M; Taratula O; Taratula O
    Theranostics; 2018; 8(3):767-784. PubMed ID: 29344305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.